Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...

For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system ...

Zydus Medtech, a subsidiary of Zydus Lifesciences, has entered into a global licensing agreement with Brazilian medical ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

South Jordan, Utah–based Merit adds the latest delivery system to its growing electrophysiology (EP) and cardiac rhythm management (CRM) portfolio. It joins solutions such as HeartSpan, Worley, ...

In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial.

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut transcatheter aortic valve replacement (TAVR) system in low-risk aortic ...

The company is rapidly expanding its interventional cardiology portfolio, and under the partnership will commercialize the ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...

Scientists have discovered that the aorta acts as a “second heart” by using a wave-pumping mechanism to support blood ...